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Tbjective: Predicting the risk factors for late aortic events in patients with type B
cute aortic dissection without complications may help to determine a therapeutic
trategy for this disorder. We investigated whether late aortic events in type B acute
ortic dissection can be predicted accurately by an index that expresses the degree
f fusiform dilatation of the proximal descending aorta during the acute phase; this
ndex can be calculated as follows: (maximum diameter of the proximal descending
orta)/(diameter of the distal aortic arch  diameter of the descending aorta at the
ulmonary artery level).
ethods: Patients with type B acute aortic dissection without complications (n 
41) were retrospectively analyzed to determine the predictors of late aortic events;
hese include aortic dilatation, rupture, refractory pain, organ ischemia, rapid aortic
nlargement, and rapid enlargement of ulcer-like projections.
esults: The fusiform index in patients with late aortic events (0.59) was higher than
hat in patients without late aortic events (0.53, P  .01). Patients with a higher
usiform index exhibited aortic dilatation earlier than those with a lower fusiform
ndex. By multivariate analysis, we conclude that the predominant independent
redictors of late aortic events were a maximum aortic diameter of 40 mm or more,
patent false lumen, and a fusiform index of 0.64 or more (hazard ratios, 3.18, 2.64,
nd 2.73, respectively). The values of actuarial freedom from aortic events for
atients with all 3 predictors at 1, 5, and 10 years were 22%, 17%, and 8%,
espectively, whereas the values in those without these predictors were 97%, 94%,
nd 90%, respectively.
onclusions: The degree of fusiform dilatation of the proximal descending aorta, a
atent false lumen, and a large aortic diameter can be predominant predictors of late
ortic events in patients with type B acute aortic dissection. Patients with these
redictors should be recommended to undergo early interventions (surgery or
tent-graft implantation) or at least be closely followed up during the chronic phase
efore such events develop.
onservative medical treatment is generally the treatment of choice for
patients with Stanford type B acute aortic dissection (AAD) without com-
plications (rupture, visceral organ ischemia, or refractory pain) in most
nstitutions, because the natural history of these patients is not severe.1-6 However,
ortic complications develop during the chronic phase in many patients who receive
edical treatment with successful results during the acute phase of this disorder.
herefore, predicting risk factors for the development of late aortic events may help
n determining a therapeutic strategy for type B AAD without complications5-12
We reported that a maximum aortic diameter of 40 mm or more and a patent false
umen during the acute phase were the predominant predictors of late aortic events
aortic diameter  60 mm, rupture, refractory pain, organ ischemia, rapid aortic
he Journal of Thoracic and Cardiovascular Surgery ● Volume 134, Number 5 1163
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A
CDnlargement  10 mm/y, and rapid enlargement of ulcer-
ike projection [ULPs]  5 mm/y) in type B AAD without
omplications.12 We suggested that patients with these p-
ictors should undergo early surgery before aortic events
ccur; however, medical treatment should be continued in
atients without these predictors.
A helical flow pattern can be observed in the part of the
ormal aorta that is distal to the aortic arch (ie, the proximal
escending aorta); however, disturbed flow patterns are
bserved in this part in patients with aneurysms and dissec-
ion.13 Once morphologic changes have occurred in 
ortic wall, this disturbed flow pattern promotes aortic di-
atation.14 As observed in true aneurysms of the distal a
rch, an initial morphologic change in the proximal de-
cending aorta (ie, fusiform dilatation) in patients with type
AAD may worsen the disturbed flow pattern and accel-
rate aneurysmal aortic dilatation. This process is less se-
ere in patients with type B AAD with a lesser degree of
nitial morphologic change in the aorta.
We hypothesized that the morphologic change in the
hape of the proximal descending aorta to a fusiform shape
uring the acute phase of type B AAD may accelerate the
ilatation of the dissected aorta during the chronic phase. To
est this hypothesis, we defined a fusiform index (FI) that
xpresses the degree of fusiform dilatation of the proximal
escending aorta. The purpose of the present study was to
valuate the acute-phase predictors of late aortic events,
ncluding the FI, and to investigate an optimal therapeutic
trategy for type B AAD without serious complications.
aterials and Methods
tudy Population
etween January 1988 and March 2004, 153 patients in the acute
hase (within 14 days of the onset) of type B AAD were admitted
o Tsuchiya General Hospital. Of these, 141 patients without
erious complications (rupture, visceral organ ischemia, or refrac-
ory pain) were entered into this study as patients who were treated
uccessfully with medical treatment during the acute phase. The
emaining 12 patients were excluded from the study because they
ad either undergone urgent surgery (n  7) (owing to a ruptured
horacic aorta, n  3; ruptured abdominal aorta, n  2; and
isceral organ ischemia, n  2) or had died of aortic rupture (n 
) or visceral organ ischemia (n  2). The age of the patients
anged from 32 to 90 years (mean age, 68 years), and 97 patients
69%) were male. Patients with AAD and Marfan syndrome were
Abbreviations and Acronyms
AAD acute aortic dissection
CT  computed tomography
FI  fusiform index
ULP  ulcer-like projectionot included (Table 1). We obtained informed consent from allv
164 The Journal of Thoracic and Cardiovascular Surgery ● Novatients. The study protocol was reviewed and approved by the
nstitutional review board, and the study complied with the Dec-
aration of Helsinki.
efinition of Fusiform Index
n index that expresses the degree of fusiform dilatation (the FI)
f the proximal descending aorta was defined as follows: A/(BC)
A, maximum diameter of the proximal descending aorta, B;
iameter of the distal aortic arch; and C, diameter of the descend-
ng aorta at the level of the origin of the main pulmonary artery)
Figure 1). In cases with retrograde dissection of the aortic 
e measured the diameter of the aortic arch at the proximal extent
f the retrograde dissection and considered this value as the “B”
alue.
iagnosis and Predictive Variables
he diagnosis of type B AAD was confirmed by contrast-enhanced
omputed tomography (CT) scanning (from 1988 to 1993 using
odel TCT-300, Toshiba Co, Tokyo, Japan; from 1994 to 2004
sing ProSpeed, GE Yokogawa Medical Systems, Tokyo, Japan)
hat was performed immediately after urgent admission. We oc-
asionally used digital subtraction angiography to evaluate the
ABLE 1. Patient characteristics for the entire study
roup (141 patients)
asic characteristics
Sex, male, n (%) 97 (69%)
Age, y (mean  SD) 68  13
’70 y, n (%) 63 (45%)
Hypertension, n (%) 104 (74%)
Diabetes mellitus, n (%) 22 (16%)
Ischemic heart disease, n (%) 33 (23%)
Cerebrovascular disease, n (%) 24 (17%)
COPD, n (%) 27 (19%)
Hemodialysis, n (%) 11 (8%)
LVEF, % (mean  SD) 62  15
70%, n (%) 40 (28%)
T findings during the acute phase
Extent of dissection, n (%)
DeBakey IIIa 52 (37%)
DeBakey IIIb 89 (62%)
Patency in the false lumen, n (%)
Patent 62 (44%)
Closed 79 (56%)
Maximum aortic diameter, n (%)
40 mm 66 (47%)
FI (median) 0.55
0.64, n (%) 35 (25%)
ollow-up variables during the chronic phase
Mean systolic blood pressure
mm Hg (mean  SD) 124  29
140 mm Hg, n (%) 20 (14%)
OPD, Chronic obstructive pulmonary disease; LVEF, left ventricular ejec-
ion fraction; CT, computed tomography; SD, standard deviation; FI, fusi-
orm index.isceral arteries to support the CT findings. We obtained the
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A
CDollowing data from the examination results: the maximum
ortic diameter (measured at any point between the aortic arch
nd the descending aorta), all aortic diameters that were re-
uired for calculating the FI, the thoracoabdominal extent of the
issection extending beyond the diaphragm, and the patency of
he false lumen. In patients in whom 3-dimensional CT data
ere available, each aortic diameter was measured using com-
ercially available software. However, in patients in whom
hese data were unavailable, we used the same methodology
hat several studies had used as a surrogate for 3-dimensional
T analysis:10,15 In this method, the largest short-axis diame
f the outer contour of the affected segment of the aorta was
easured. In the aortic arch, the largest diameter perpendicular
o the curvature was measured. The diameters were measured
rom hardcopy images using direct-reading calipers and cor-
ected for the appropriate scale. These findings were reviewed
y an experienced radiologist in a blind manner.
These data on the acute phase, along with the basic character-
stics of the patients (sex, age, and presence of a concomitant
edical condition such as hypertension, diabetes mellitus, isch-
mic heart disease, cerebrovascular disease, chronic obstructive
ulmonary disease, hemodialysis, and left ventricular ejection
raction), were evaluated as predictive variables of late aortic
vents during the chronic phase. In addition, the mean systolic
lood pressure, which was obtained from serial blood pressure
easurements during the chronic phase, was also considered as a
redictive variable of late aortic events (Tables 1 and 2).
ollow-up Study and Definitions of
redictive Variables
ll 141 patients received medical treatment during the acute
nd chronic phases as previously described.12 The chronic
igure 1. Definition of FI. An index that expresses the degree of
usiform dilatation of the proximal descending aorta was defined
s follows: A/(B C). A  Maximum diameter of the descending
orta. B Diameter of the distal aortic arch. C Diameter of the
escending aorta at the level of the origin of the main pulmonary
rtery.hase started from day 14 after the onset of AAD.2,4,5 The w
The Journal of Thoracicriteria used to define late aortic events during the chronic
hase were (1) maximum diameter of the dissected aorta of 60
m or more; (2) rupture of the dissected aorta; (3) refractory
ain; (4) visceral organ ischemia; (5) rapid enlargement of the
issected aorta by 10 mm or more per year; and (6) rapid
nlargement of ULPs by 5 mm or more per year. We obtained
he expansion rate of each dissected aorta or ULP by calculating
he difference in diameter between the initial measurement and
hat at the most recent follow-up and dividing this value by the
ime interval between the 2 measurements. All of the 141
atients with type B AAD who had received medical treatment
uring the acute phase of this disorder were followed up on an
utpatient basis (Table 2). The blood pressure was meas
very month. A CT scan was performed every 1 to 34 months
mean, 16.3 months). The CT images of all patients at urgent
dmission and during follow-up were available.
tatistical Analysis
ll continuous variables are expressed as the mean  standard
eviation. Comparison of the clinical and radiologic characteristics
as performed by the chi-square analysis for categoric variables
nd by Student t test for continuous variables. To determine
ABLE 2. Characteristics of patients with and without late
ortic events (141 patients)
Events No events
(n  59) (n  82)
asic characteristics
Sex, male, n (%) 42 (71%) 55 (67%)
Age  70 y, n (%) 24 (41%) 39 (48%)
Hypertension, n (%) 47 (80%) 57 (70%)
Diabetes mellitus, n (%) 13 (22%) 9 (11%)
Ischemic heart disease, n (%) 19 (32%) 14 (17%)
Cerebrovascular disease, n (%) 15 (25%) 9 (11%)
COPD, n (%) 9 (15%) 18 (22%)
Hemodialysis, n (%) 7 (12%) 4 (5%)
LVEF  70%, n (%) 21 (36%) 19 (23%)
T findings during the acute phase
Extent of dissection, n (%)
DeBakey IIIa 23 (39%) 29 (35%)
DeBakey IIIb 36 (61%) 53 (65%)
Patency in the false lumen, n (%)
Patent 35 (59%) 27 (33%)
Closed 24 (41%) 55 (67%)
Maximum aortic diameter, n (%)
40 mm 39 (66%) 27 (33%)
40 mm 20 (34%) 55 (67%)
FI, n (%)
0.64 23 (39%) 12 (15%)
0.64 36 (61%) 70 (85%)
ollow-up variables
Mean systolic blood pressure, n (%)
140 mm Hg 9 (15%) 11 (13%)
OPD, Chronic obstructive pulmonary disease; LVEF, left ventricular ejec-
ion fraction; FI, fusiform index.hether the FI is a predictive factor, we divided the patients into
and Cardiovascular Surgery ● Volume 134, Number 5 1165
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1
A
CDgroups according to the 25th, 50th, and 75th percentiles of the FI
0.49, 0.55, and 0.64, respectively). A Cox proportional hazards
odel was used to identify the predominant predictors of late
ortic events throughout the entire follow-up period by stepwise
ultivariate analyses. A stepwise selection method was used with
significance level of .10 for entering a variable into the model
nd .05 for retaining an explanatory variable from the model. The
alues of actuarial freedom from late aortic events were computed
y using the Kaplan–Meier technique, and event-free curves were
ompared using the log-rank test. Data analysis was performed
ith StatView 5.0 for Windows (SAS Institute Inc, Cary, NC).
esults
f the 141 patients, 59 (42%) met the criteria for the
evelopment of late aortic events during the chronic phase.
he mean duration between the onset of AAD and the most
igure 2. FI and late aortic events. A, Comparison of the FI
etween patients with and without late aortic events: Levels of FI
re demonstrated by the box showing the 25th to 75th percentiles
ontaining the median line and the lines showing the 10th to 90th
ercentiles. B, Kaplan–Meier event-free curves for late aortic
vents according to quartiles of the FI. Q, Quartile of FI: Q1
<0.49), Q2 (<0.49, <0.55), Q3 (<0.55, <0.64), Q4 (<0.64).ecent CT scan was 55.7 months and 49.3 months in the l
166 The Journal of Thoracic and Cardiovascular Surgery ● Novatient groups with and without late aortic events, respec-
ively. The follow-up data were 98% complete, and the
ean follow-up period was 64.4 months (range, 1-157
onths). There was no significant difference in the mean
ollow-up periods between the 2 groups (68.1 vs 61.7
onths).
In the 59 patients who met the criteria for late aortic
vents, the follow-up period from the onset of AAD to the
evelopment of the events was 1 to 132 months. Of these
atients, 39 (67%) had a maximum aortic diameter of 60
m or more, 4 (7%) had aortic rupture, 2 (3%) had refrac-
ory pain, 2 (3%) had visceral organ ischemia, 9 (15%) had
apid aortic enlargement, and 3 (5%) had rapid enlargement
f ULPs. Of the 59 patients, 54 (92%) underwent surgery; 3
5%) did not undergo surgery because of poor general
ondition, and 2 (3%) refused surgery. Of the 54 patients
ho underwent surgery, 5 (9%) died after the first surgery
n the chronic phase (2 died of hemorrhage, 2 died of acute
enal failure, and 1 died of bronchial occlusion resulting
rom hemorrhage from the aortopulmonary fistula). Two
atients (4%) died of aortic rupture at 24 and 66 months
fter the first operation. Four patients (7%) died of nonaortic
vents (2 died of cancer, 1 died of stroke, and 1 committed
uicide) after the first surgery. Of the 89 patients who did
ot meet the criteria for the late aortic events, 13 (15%) died
uring the follow-up period (2 died of rupture of the dis-
ected aorta, 6 died of cancer, 3 died of heart failure, 1 died
f pneumonia, and 1 died of sudden death of unknown
ause). Three patients (4%) requested and underwent sur-
ery before the development of late aortic events.
Figure 2, A shows a comparison between the FIs of 
atients with and without late aortic events. The FI of
atients with late aortic events (median value, 0.59) was
ignificantly higher than that of patients without late aortic
vents (median value 0.53, P  .01). The patients were
ivided into 4 groups according to the 25th, 50th, and 75th
ercentiles of the FI (0.49, 0.55, and 0.64, respectively).
igure 2, B shows the event-free curves for late aortic ev
ccording to the quartiles of the FIs. Patients with the
ighest quartile had a significantly higher prevalence of late
ortic events during the entire follow-up period (P for trend
.0033). Therefore, we used the highest quartile (FI 
.64) as a predictor of late aortic events for univariate and
ultivariate analyses.
Univariate variables that were significantly associated
ith late aortic events included ischemic heart disease (P 
036), cerebrovascular disease (P  .043), a patent false
umen (P  .0018), a maximum aortic diameter of 40 mm
r more (P  .001), and an FI of 0.64 or more (P  .001)
Table 3). All significant univariate variables were ente
nto the Cox proportional hazards model. A maximum aor-
ic diameter of 40 mm or more (P  .01), a patent false
umen (P  .024), and an FI of 0.64 or more (P  .013)
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A
CDere shown to be significant predictors of late aortic events.
he hazard ratio for the presence of a maximum aortic
iameter of 40 mm or more was 3.18 times higher than that
or a maximum aortic diameter of less than 40 mm (95%
onfidence interval; range, 2.12–5.05); for a patent false
umen, this ratio was 2.64 times higher than that for a closed
alse lumen (95% confidence interval; range 1.62–4.03).
he hazard ratio for an FI of 0.64 or more was 2.73 times
igher than that for an FI of less than 0.64 (95% confidence
nterval; range 1.85–4.60). The values of actuarial freedom
rom late aortic events for patients with 1 of these predictors
Figure 3, A) were as follows. At 0.5, 1, 5, and 10 
hese values were 81%, 77%, 61%, and 41%, respectively,
or patients with a patent false lumen (group P); 84%, 74%,
6%, and 40%, respectively, for patients with a maximum
ortic diameter of 40 mm or more (group M); and 78%,
4%, 44%, and 44%, respectively, for patients with an FI of
.64 or more (group F). These curves were not significantly
ifferent from each other (P  .72).
To obtain a more accurate estimation of the late aortic
vents, we analyzed the event-free curves for the following
roups: patents with a maximum aortic diameter of 40 mm
r more with a concomitant patent false lumen (group MP),
atients with a maximum aortic diameter of 40 mm or more
ith an FI of 0.64 or more (group MF), and patients with a
atent false lumen with an FI of 0.64 or more (group PF).
he values of actuarial freedom from the late aortic events
t 0.5, 1, 5, and 10 years were 65%, 51%, 31%, and 21%,
ABLE 3. Statistical analysis of predictors for late aortic
vents
Univariate Multivariate
redictive factor 2 P P
Hazard Ratio
(95% CI)
ex 0.27 .60
ge  70 y 0.66 .42
ypertension 1.83 .18
iabetes mellitus 2.40 .12
schemic heart disease 4.38 .036 .45 1.67 (0.96-2.81)
erebrovascular disease 4.10 .043 .63 1.53 (0.78-2.67)
OPD 0.61 .44
emodialysis 1.46 .23
VEF  70% 2.61 .11
ype (DeBakey IIIa/b) 0.19 .66
atent false lumen 9.70 .0018 .024 2.64 (1.62-4.03)
ortic diameter  40 mm 15.2 .001 .01 3.18 (2.12-5.05)
I  0.64 10.9 .001 .013 2.73 (1.85-4.60)
ean systolic blood
pressure during follow-
up (140 mm Hg)
1.75 .19
I, Confidence interval; COPD, chronic obstructive pulmonary disease;
VEF, left ventricular ejection fraction; FI, fusiform index.espectively, for group MP; 52%, 33%, 21%, and 14%, 4
The Journal of Thoracics,
espectively, for group MF; and 55%, 35%, 24%, and 24%,
espectively, for group PF (Figure 3, B). The values o
ctuarial freedom from late aortic events for patients with
ll 3 predictors (group MPF) at 0.5, 1, 5, and 10 years were
igure 3. Kaplan–Meier event-free curves for late aortic events.
, Event-free curves of patients with 1 of the predominant pre-
ictors. M: Patients with a maximum aortic diameter of > 40 mm.
: Patients with a patent false lumen. F: Patients with an FI of >
.64. B, Event-free curves of patients with 2 predominant predic-
ors. MP: Patients with a maximum aortic diameter of > 40 mm
nd a patent false lumen. MF: Patents with a maximum aortic
iameter of > 40 mm and an FI of > 0.64. PF: Patients with a
atent false lumen and an FI of > 0.64. C, Event-free curves of
atients with all 3 or none of the predominant predictors. N:
atients with none of the 3 predictors. MPF: Patients with all 3
redictors (a maximum aortic diameter of> 40 mm, a patent false
umen, and an FI of > 0.64).4%, 22%, 17%, and 8%, respectively, whereas those for
and Cardiovascular Surgery ● Volume 134, Number 5 1167
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1
A
CDhe patients with none of these predictors (group N) were
7%, 97%, 94%, and 90%, respectively (Figure 3, C).
iscussion
he optimal indication for and timing of surgery in patients
ith Stanford type B AAD without complications have been
ontroversial. We have suggested 2 therapeutic options for
uch patients that might provide better long-term results:
atients with predictors of late aortic events should undergo
arly surgery, whereas those without these predictors should
ontinue to receive medical treatment.12
In the present study, the results indicated that late aortic
vents in type B AAD can be predicted by 3 independent
cute-phase factors: a maximum diameter of the dissected
orta of 40 mm or more, a patent false lumen, and an FI of
.64 or more. Patients with even 1 of these predictors should
igure 4. Comparison of the event-free curves between patients
ith 1 and 2 predictors. A, M: Patients with a maximum aortic
iameter of > 40 mm. MF: Patents with a maximum aortic diameter
f > 40 mm and an FI of > 0.64. B, P: Patients with a patent false
umen. PF: Patients with a patent false lumen and an FI of > 0.64.e recommended early interventions (surgery or stent-graft s
168 The Journal of Thoracic and Cardiovascular Surgery ● Novmplantation) to prevent the development of late aortic
vents. However, the event-free rates of patients with 1 of
hese predictors at 10 years were approximately 40% to
0%; this indicated that approximately half of the patients
an be treated medically on a long-term basis (Figure 3A).
fter careful observation, we concluded that patients with 1
f these predictors can be treated medically as long as the
ortic diameter does not increase.
The presence of more than 1 of these predictors in a
atient may be regarded as a more reliable indication for
urgical intervention. Other studies, in addition to our study,
eported that a maximum aortic diameter of 40 mm or more
nd a patent false lumen are the predominant predictors of
ate aortic events.6-12 In the present study, the event-fr
urves of patients with a maximum aortic diameter of 40
m or more and an FI of 0.64 or more (group MF) were
ignificantly different from those of patients with a maxi-
um aortic diameter of 40 mm or more alone (group M)
Figure 4, A, P  .018). Similarly, the event-free curves 
atients with a patent false lumen and an FI of 0.64 or more
group PF) was also significantly different from those of
atients with a patent false lumen alone (group P) (Figu
, P  .026). Therefore, a combination of the previously
nown predictors with an FI of 0.64 or more may aid in
redicting late aortic events more accurately. We recom-
end early interventions or at least close follow-up for
atients with 2 of these predictors. Most important, the
vent-free rates of patients with all 3 predictors (group
PF) at 1, 5, and 10 years were 22%, 17%, and 8%,
espectively; these values were considerably lower than
hose of the MP, MF, and PF groups. In view of this, we
uggest that patients with all 3 predominant predictors
hould be recommended surgical interventions during the
ubacute or early chronic phase before late aortic events can
evelop.
On the other hand, most patients without predictors
group N) showed good long-term results because the dis-
ected aorta showed a natural course of recovery (Figu
). The event-free rates of group N (n  35) at 1, 5, and 10
ears (97%, 94%, and 90%, respectively) were satisfactory.
one of the patients in this group died of aortic events, and
2 patients (34%) showed a reduction in the aortic diameter.
herefore, patients who are expected to have a lower prob-
bility of developing late aortic events should not be rec-
mmended surgery during the acute phase and should con-
inue to receive medical treatment.
A higher FI may predict earlier aortic dilatation. The
vent-free rate at 1 year for group F (44%) was considerably
ower than that for group P (77%) or group M (74%),
hereas the event-free rate of group F at 10 years (44%)
as close to that of group P (40%) or group M (41%). The
vent-free curves of these groups (P, M, and F) were not
ignificantly different from each other (Figure 3, A). These
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A
CDesults indicate that the expansion of the aortic diameter in
atients with a higher FI may be faster than that in patients
ith a lower FI, although the number of patients who
eveloped late aortic events on a long-term basis was equal
n both groups.
In the present study, we focused on the degree of fusi-
orm dilatation of the proximal descending aorta as a pre-
ictor of late aortic events in patients with type B AAD. The
nitial change in the formation of an aneurysm is struc
nd results from a degenerative process in the vessel w14
nce the morphologic change has occurred, the blood flow
attern is likely to change, thereby leading to alterations in
he shear stresses and consequent strain; this accelerates the
evelopment of the aneurysm so that a vicious circle is
reated. The geometry of the aorta is altered during aneu-
ysmal degeneration, and the geometric relationship be-
ween the transverse and distal segment of the aortic arch
ecomes increasingly distorted during the process of devel-
pment of a distal arch aortic aneurysm.13,14,16 In a fusiform
ilatation of the proximal descending aorta, the magnitude
f the initial morphologic change may be much more than
hat in a non-fusiform proximal descending aorta; this wors-
ns the disturbed flow pattern and may result in accelerating
he dilatation of the proximal descending aorta. The outer
urvature of the dissected aortic wall, which often consists
f adventitia and dissected media, was thin and fragile and
ay also accelerate the dilatation of the aorta. We did not
se the location of the entry site as a predictor because the
ocation of the entry sites could not be accurately confirmed
n any patient. However, in most of the patients with a high
I who developed late aortic events, the entry site was
ocated at the distal arch. This may support the hypothesis
hat the flow-pattern disturbances in the proximal descend-
ng aorta directly lead to aortic dilatation.
There are some limitations to the present study. First,
here were difficulties in obtaining accurate measurements
f the aortic diameter on axial-CT images. We used 3-
imensional CT to determine the dimensions of the segment
f the aorta under consideration. However, in patients in
hom the 3-dimensional CT data were unavailable, we used
measurement method with axial-CT scan reports similar to
he method used in several studies.10,15 In addition, we di
ot consider the laterality of the aortic diameters. The mea-
urements used in the present study may have underesti-
ated the aortic diameter in some cases. Second, other
actors such as blood-flow velocity and flow-pattern distur-
ances in the proximal descending aorta, which may influ-
nce the development of late aortic events, were not eval-
ated in the present study. Finally, the recent advent of
ndovascular-stent grafting may change the therapeutic
trategies for type B AAD.3,5,17-27
In summary, a maximum aortic diameter of 40 mm or
ore, a patent false lumen, and an FI of 0.64 or more during
The Journal of Thoracicl
he acute phase of type B AAD without complications were
redominant independent predictors of the late aortic events
ssociated with this disorder. A higher FI value might help
o predict the late aortic events earlier. Patients without
hese predictors should continue to receive conventional
edical treatment because they are predicted to have a
atisfactory natural course of recovery of the dissected
orta. On the contrary, patients with 1 of these predictors
an be treated medically but with close follow-up. Patients
ith 2 of the predominant predictors should be considered
or early intervention (surgery or stent-graft implantation)
r at least close follow-up. Patients with all 3 predictors are
trongly predicted to have a high incidence of developing
ate aortic events; therefore, they should undergo the inter-
ention during the subacute or early chronic phase before
ate aortic events can develop.
onclusions
he degree of fusiform dilatation of the proximal descend-
ng aorta in patients with Stanford type B AAD without
omplications can be used to predict late aortic adverse
vents. This predictor may be useful for developing safer
nd less-invasive treatment strategies for type B AAD with-
ut complications.
We thank Professor Masashi Komeda (Department of Cardio-
ascular Surgery, Kyoto University) for helpful suggestions and
omments, and Masaya Yamamoto (The Institute for Frontier
edical Sciences, Kyoto University) for statistical collaboration in
his article.
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